For researchers
Every eligible patient,
seen in time.
TrialLens screens each patient against every open stroke protocol at your site, ranked by fit, during the acute workup.
Enrollment
Every open protocol checked for every patient, with the reasons for each match.
Rigorous evaluation
LUCID was benchmarked on 225 guideline decision points against three frontier language models.
Academic roots
Built by the NeuroPrecision Lab and licensed by the University of Pittsburgh.
Before you ask.
Can we use LUCID or TrialLens in a study?
Yes. Contact us to discuss a research agreement and the right setup for your protocol.
Where are the benchmark methods?
On the Evidence page: decision points, comparators, measures and statistics.
Does TrialLens enroll patients?
No. It surfaces candidates and reasons; consent and enrollment stay with your study team.
See LUCID on your own cases.
A 30-minute walkthrough with the team that built it.